🔗 Share this article

An underground market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to recent findings.

Experimental Drug Gaining Popularity Online

Retatrutide, which remains in clinical trials, is being promoted by online personalities for its supposed weight-reducing effects. Followers are urged to contact these profiles directly for source information, while also obtaining promotional offers.

Thriving Commerce on Social Networks

Additionally, a flourishing trade exists on messaging services, where communities with numerous of participants share “before and after” images, injection guides and claims of rapid UK delivery. Vendors promote the drug there before directing buyers to WhatsApp for transactions.

Learning About The Experimental Drug

Retatrutide is an investigational injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could assist individuals lose up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the next Ozempic.

Healthcare Professionals Voice Concerns

However, doctors and pharmacists have cautions that the sale of what is still an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering products of unknown origin.

Several professionals stated the popularity for the experimental drug could be linked to the rising price of licensed slimming products such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unapproved medication that must not be promoted or supplied for human use under the British medical regulations.

Several content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still violate pharmaceutical, marketing, and consumer laws, risking penalties, prosecution or imprisonment.

Platform Response and Content Elimination

According to the social media company, the service has removed problematic material and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Marketplace Operations

Research also found communities with up to nine thousand members marketing retatrutide using the platform's built-in search feature, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with numerous of users, populated with images of weight loss, glowing testimonials and detailed instructions for preparing or administering at residence.

After moments of entering one group, a seller posted WhatsApp details, where most transactions take place. The seller sent an guidebook and promised shipping within two days. When asked whether the product was genuine, one vendor said: “You can’t be sure.” Another provided a photo of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.

Product Information and Pricing

Inside these communities, posts display dark colored packages with postal service stickers, stating to include fresh supplies. One message read: “It took eight of us to load them this morning.”

Customers can select between dry substance containers, prepared at residence with sterile water, or pre-filled pens typically priced at £160 for 20mg. When asked how much time a injector should last, vendors give conflicting answers ranging from a several days to “depends on your body”.

Platform Moderation and Security Measures

A spokesperson for Telegram said it actively moderated dangerous content on its platform including material that encouraged the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Cautions

“Individuals are injecting substances they cannot confirm. Although the science behind this drug is sound, these digital products may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the surge in demand to current cost increases for approved slimming medications such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly dangerous. You cannot know what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has already encountered individuals harmed by personal administration from unverified sources. “We understand the frustration, but purchasing from Telegram or WhatsApp is gambling with your well-being,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated retatrutide was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a company investigational substance not yet authorized … may subject patients to potentially serious medical dangers”.